Author

Jocelin Chen

University of California, San Francisco

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Andrew LewisiD· 1 shared Antonina Jaroszewska· 1 shared Arun P. WiitaiD· 1 shared Chih-Hao ChangiD· 1 shared Chris R. HackleyiD· 1 shared Christopher A. PiggottiD· 1 shared Cindy Ament· 1 shared Corynn KasapiD· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andrew LewisORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Identification of TM4SF1 as a novel tumor-associated antigen in biliary tract cancers targetable by CAR-T cell therapy

Lorraine Nuniz, Julia H. Pham, Juliette Jacques, Corynn Kasap, Jocelin Chen, Jon Akutagawa, Josephine A. Hinneh, Chih-Hao Chang, Cindy Ament, Andrew Lewis, Arun P. Wiita, Jonathan Chou, R. Katie Kelley, Kwun Wah Wen, Vipul Kumar, Franklin W. Huang

This study identifies TM4SF1 as a tumor-associated antigen in biliary tract cancers and shows anti-TM4SF1 CAR-T cells inhibit tumor growth in vitro and in vivo.

bioRxiv · Oct 30, 2026 · PreprintCancer Biology

Methods and techniques enabling multi-kilobase long-range genomic rewrite/replace editing

Christopher A. Piggott, Laurentia V. Tjang, Selina Chen, Utsav Tatu, Hannah Hirou, Antonina Jaroszewska, Emma McIntyre, Jocelin Chen, Joelle V Faybishenko, Richard V Gavan, Chris R. Hackley

This paper introduces a method to rewrite large genomic regions using CRISPR/Cas9, enabling simultaneous editing of 7kb+ DNA sections without selection.

bioRxiv · Aug 5, 2023 · PreprintGenetics